Mediamedic/LinkedIn
Oct 4, 2025, 10:05
ISEH 2025 China–Japan Dialogue With Professors Jianxiang Wang and Naoki Hosen
Mediamedic shared a post on LinkedIn:
“ISEH 2025 China–Japan Dialogue | Professors Jianxiang Wang & Naoki Hosen: CAR-T Therapy for Leukemia and Global Collaboration
At the 54th ISEH Annual Scientific Meeting in Kumamoto, Japan, Professor Jianxiang Wang (Institute of Hematology & Blood Diseases Hospital, CAMS) and Professor Naoki Hosen (Osaka University) engaged in a deep dialogue on the future of CAR-T therapy for leukemia.
Their conversation explored basic mechanisms, clinical applications, efficacy optimization, and future directions, highlighting the importance of international collaboration to expand innovation and patient access worldwide.”
Stay updated with Hemostasis Today.
-
Apr 13, 2026, 04:18Stephen Cornelissen: You Might Be Eligible to Donate Blood – Here’s Why It’s Worth Checking
-
Apr 13, 2026, 04:12Angie Read: A Powerful Conversation on Survival, Recovery, and Purpose on Stroke Sisters’ Latest Episode
-
Apr 13, 2026, 04:04Ramy Abdelnaby: Telestroke Rounds Show Superior Guideline Adherence in Subacute Care
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow